NasdaqCM - Nasdaq Real Time Price USD

Cellectar Biosciences, Inc. (CLRB)

Compare
0.2695
-0.0237
(-8.08%)
As of 10:42:03 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
51,777.6980
51,777.6980
38,960.6430
28,813.7730
24,131.2800
Operating Income
-51,777.6980
-51,777.6980
-38,960.6430
-28,813.7730
-24,131.2800
Net Non Operating Interest Income Expense
1,210.8530
1,210.8530
387.1470
152.5190
2.2840
Other Income Expense
6,051.3990
6,051.3990
-4,257.1140
-3,191.3640
6.6340
Pretax Income
-44,515.4460
-44,515.4460
-42,830.6100
-31,852.6180
-24,122.3620
Tax Provision
66
66
-60
-60
--
Net Income Common Stockholders
-44,581.4460
-44,581.4460
-42,770.6100
-31,792.6180
-24,122.3620
Diluted NI Available to Com Stockholders
-44,581.4460
-44,581.4460
-42,770.6100
-31,792.6180
-24,122.3620
Basic EPS
-1.23
-1.22
-3.50
-4.05
-4.30
Diluted EPS
-1.41
-1.40
-3.50
-4.05
-4.30
Basic Average Shares
29,901.4780
36,622.4740
12,221.5710
7,055.6650
5,551.5720
Diluted Average Shares
30,422.7730
37,143.7690
12,221.5710
7,055.6650
5,551.5720
Total Operating Income as Reported
-51,777.6980
-51,777.6980
-38,960.6430
-28,813.7730
-24,131.2800
Total Expenses
51,777.6980
51,777.6980
38,960.6430
28,813.7730
24,131.2800
Net Income from Continuing & Discontinued Operation
-44,581.4460
-44,581.4460
-42,770.6100
-31,792.6180
-24,122.3620
Normalized Income
-55,479.2456
-55,479.2456
-38,988.8012
-35,419.3192
-24,122.3620
Interest Income
1,210.8530
1,210.8530
387.1470
152.5190
2.2840
Net Interest Income
1,210.8530
1,210.8530
387.1470
152.5190
2.2840
EBIT
-51,777.6980
-51,777.6980
-38,960.6430
-28,813.7730
-24,131.2800
EBITDA
-51,486.0450
-51,486.0450
-38,768.2680
-28,665.3380
-23,981.3650
Reconciled Depreciation
291.6530
291.6530
192.3750
148.4350
149.9150
Net Income from Continuing Operation Net Minority Interest
-44,581.4460
-44,581.4460
-42,770.6100
-31,792.6180
-24,122.3620
Total Unusual Items Excluding Goodwill
13,794.6830
13,794.6830
-3,787.1140
3,633.2410
--
Total Unusual Items
13,794.6830
13,794.6830
-3,787.1140
3,633.2410
--
Normalized EBITDA
-65,280.7280
-65,280.7280
-34,981.1540
-32,298.5790
-23,981.3650
Tax Rate for Calcs
0.0002
0.0002
0
0
--
Tax Effect of Unusual Items
2,896.8834
2,896.8834
-5.3052
6.5398
--
12/31/2021 - 11/10/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ASMB Assembly Biosciences, Inc.
8.61
-7.42%
 
HLVX HilleVax, Inc.
1.4411
-0.61%
 
EPIX ESSA Pharma Inc.
1.5450
-2.22%
 
SPRO Spero Therapeutics, Inc.
0.5702
-8.55%
 
KROS Keros Therapeutics, Inc.
10.10
-1.80%
 
GLTO Galecto, Inc.
2.6850
-6.12%
 
RPTX Repare Therapeutics Inc.
1.0050
-4.29%
 
ANTX AN2 Therapeutics, Inc.
1.3300
-5.00%
 
KZR Kezar Life Sciences, Inc.
4.0850
-9.22%
 
VTYX Ventyx Biosciences, Inc.
0.9387
-6.13%